XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 200,858 $ 243,576
Trade accounts receivable, net of allowances of $442 and $444 at June 30, 2024 and December 31, 2023, respectively 109,073 108,240
Deferred contract costs 25,727 23,508
Prepaid expenses 18,518 14,255
Other current assets 19,823 13,055
Total current assets 373,999 402,634
Equipment and leasehold improvements, net 14,264 15,184
Goodwill 885,404 887,121
Other intangible assets, net 167,779 187,891
Deferred contract costs, non-current 55,897 53,070
Other assets 49,398 43,752
Total assets 1,546,741 1,589,652
Current liabilities:    
Accounts payable 18,901 25,909
Accrued liabilities 73,782 77,447
Income taxes payable 1,467 1,248
Deferred revenue 314,893 317,546
Total current liabilities 409,043 422,150
Deferred revenue, non-current 55,313 55,886
Deferred tax liability, net 5,021 5,952
Convertible senior notes, net 368,248 366,999
Other liabilities 16,866 21,118
Total liabilities 854,491 872,105
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value, 50,000,000 shares authorized at June 30, 2024 and December 31, 2023; no shares issued and outstanding at June 30, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value, 500,000,000 shares authorized at June 30, 2024 and December 31, 2023; 127,466,599 and 126,938,102 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 124 126
Additional paid‑in capital 1,214,340 1,162,993
Accumulated other comprehensive loss (28,278) (26,777)
Accumulated deficit (493,936) (418,795)
Total stockholders’ equity 692,250 717,547
Total liabilities and stockholders’ equity $ 1,546,741 $ 1,589,652